Characterizing Cell Therapy Products with Potency Assays in Early Development
Time: 11:30 am
day: Day 2 - Track A - Morning
Details:
- Explore the use a matrix of assays including IFN-y, cytotoxicity and cytokine panels
- Use surrogate markers, functional outputs, and in vitro models to establish early correlation with intended therapeutic effect
